BioSpace News Archive

TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best-in-class quality check, to cell and gene therapy leader Imagine Institute

Based on biomimetic stem cell culture in 3D, C-Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability

April 17, 2019
·
3 min read
Deals

Notice of Annual General Meeting in Promore Pharma AB (publ)

Promore Pharma AB calls for Annual General Meeting Tuesday 21 May 2019 at 2 pm at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm.

April 17, 2019
·
8 min read
FDA

Karolinska Development’s portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-246

Karolinska Development’s portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes having a TP53 mutation.

April 17, 2019
·
3 min read
FDA

Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders

Company on Track to Submit NDA to FDA in Mid-2019

April 17, 2019
·
5 min read
Quantum dot imaging advances

Luminescing nanosized crystals are showing promise for peering deeply into body tissues, but first they need to be made safe.

April 17, 2019
·
2 min read
The National Centre for Research and Development Awards Orion Biotechnology With a Grant to Progress Development of a Treatment for Advanced Colorectal Cancer

Orion Biotechnology Canada Ltd. announced that its European subsidiary Orion Biotechnology Polska Sp. z.o.o. was awarded a grant of just under two million U.S. dollars by the Polish National Centre for Research and Development (NCBR).

April 17, 2019
·
2 min read
Policy

Bioprinting: Poietis announces the award of a third new major European patent

Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology

April 17, 2019
·
2 min read
Business

PureTech Health Inks Deal with Boehringer Ingelheim for Immuno-Oncology

PureTech, which has headquarters in Boston, but is listed in London, signed a research collaboration deal with Germany’s Boehringer Ingelheim. The companies will work to develop novel product candidates using PureTech’s proprietary lymphatic targeting technology for immune modulation.

April 17, 2019
·
3 min read
·
Mark Terry
Pharm Country

Lannett Shares Fall After Article Raises Questions Regarding Anti-Trust Lawsuits and Potential Fines

The pseudonym-penned article contends 2013 and 2014 price increases for two Lannett Drugs were part of a multi-company price-fixing scheme.

April 17, 2019
·
2 min read
·
Alex Keown
Deals

Kiadis Will Marry Its T-Cell Platform to CytoSen’s NK-Cell Platform in All-Stock Deal

The combination of the two companies will create a leader in cell-based cancer immunotherapy, Kiadis said. It also further expands Kiadis’ toehold in the United States.

April 17, 2019
·
3 min read
·
Alex Keown